Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02297256 · ClinicalTrials.gov registry record · NA
Prospective Study of Thoracolumbar Spinal Fusion Graft
A NA study of Lumbar Degenerative Disc Disease, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 3
- Study locations
NCT02297256: Active NA study of Lumbar Degenerative Disc Disease, sponsored by NYU Langone Health.
NCT02297256 is a NA study of Lumbar Degenerative Disc Disease that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02297256, a NA study of Lumbar Degenerative Disc Disease, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is a single-center, prospective randomized clinical study intended to compare and evaluate the efficacy of subjects who are treated with bone marrow aspirate concentrate (BMAC) and allograft to iliac crest bone grafts (ICBG) during posterior lumbar/lumbosacral spinal fusion.
Primary Outcome
Spinal fusion grade refers to the assessment of how well vertebrae fuse together after surgery, often evaluated using imaging like CT scans or radiographs. Grades typically range from complete fusion (Grade I) to non-union or pseudarthrosis (Grade IV), indicating varying degrees of bone healing and stability.
Conditions Studied
Interventions
- PROCEDURE Iliac Crest Bone Graft
- PROCEDURE BMAC & Allograft
Study Locations (3)
New York
- NYU Hospital for Joint Diseases - New York
- Center for Musculoskeletal Care (CMC) - New York
- NY Spine Institute - Westbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-08 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What the registry record for NCT02297256 still lists
NCT02297256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Lumbar Degenerative Disc Disease appearing as the primary indexed condition, and to 2 interventions - of which Iliac Crest Bone Graft is the first listed.
NCT02297256 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02297256 about?
NCT02297256 is a clinical study titled "Prospective Study of Thoracolumbar Spinal Fusion Graft". This study is a single-center, prospective randomized clinical study intended to compare and evaluate the efficacy of subjects who are treated with bone marrow aspirate concentrate (BMAC) and allograft to iliac crest bone grafts (ICBG) during posterior lumbar/lumbosacral spinal fusion.
What is the current status of trial NCT02297256?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2012-08. Estimated completion is 2025-12-01.
What conditions does trial NCT02297256 study?
This clinical trial studies the following conditions: Lumbar Degenerative Disc Disease.
What interventions are being tested in trial NCT02297256?
The interventions under investigation include: Iliac Crest Bone Graft (PROCEDURE), BMAC & Allograft (PROCEDURE).
Who is sponsoring clinical trial NCT02297256?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02297256 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbar Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02297256's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia